Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 7, 2015; 21(9): 2629-2637
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2629
Published online Mar 7, 2015. doi: 10.3748/wjg.v21.i9.2629
Figure 1 Frequency of detecting methylated DNA in the plasma of colorectal cancer, adenomas, and control samples.
Figure 2 Representative methylation-specific polymerase results of GATA5 (A), SFRP2 (B) and ITGA4 (C) aberrant methylation in colorectal cancer, adenomas, and control patients.
U: Results obtained using unmethylated primers; M: Results obtained using methylated primers.
- Citation: Zhang X, Song YF, Lu HN, Wang DP, Zhang XS, Huang SL, Sun BL, Huang ZG. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas. World J Gastroenterol 2015; 21(9): 2629-2637
- URL: https://www.wjgnet.com/1007-9327/full/v21/i9/2629.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i9.2629